Polycystin-L2 inhibitors encompass a variety of chemical compounds that exert their inhibitory effects by altering calcium homeostasis and signaling pathways that are crucial for the proper functioning of Polycystin-L2. These inhibitors include certain organic solvents that induce oxidative stress and disrupt calcium signaling, potentially diminishing the protein's function by impairing its ability to regulate calcium-dependent processes. Calcium channel blockers are another class that contributes to the inhibition of Polycystin-L2 by preventing calcium influx into cells. By doing so, they alter the intracellular calcium levels, which are fundamental for Polycystin-L2's activity, thereby potentially reducing its functional role in cellular signaling. Additionally, ionophores that perturb ion gradients, particularly calcium, could lead to a reduction in Polycystin-L2's function by disrupting the precise calcium balance required for its activation.
Selective inhibitors targeting specific calcium receptors and channels are also instrumental in inhibiting Polycystin-L2. Antagonists of the inositol triphosphate receptor, for instance, affect the release of calcium from the endoplasmic reticulum, which is a key step in calcium signaling pathways involving Polycystin-L2. Compounds that inhibit calcineurin, a phosphatase involved indephosphorylation processes that can affect Polycystin-L2, consequently reduce the protein's activity by altering its phosphorylation state. Compounds that influence electrolyte flux can indirectly decrease Polycystin-L2 activity by systemic alterations in calcium balance. Furthermore, specific antagonists of ryanodine receptors disrupt calcium release from the sarcoplasmic/endoplasmic reticulum, crucial for Polycystin-L2 signaling, therefore potentially inhibiting its function. The use of agents that block multiple types of calcium channels further supports the inhibition of Polycystin-L2 by preventing both calcium entry and release within cells, emphasizing the protein's dependency on calcium signaling for its activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichloroethylene | 79-01-6 | sc-251310 sc-251310A | 500 ml 1 L | $65.00 $108.00 | ||
This compound's effects involve oxidative stress and disruption of calcium signaling, potentially diminishing Polycystin-L2's function. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
This calcium channel blocker interferes with calcium homeostasis which is essential for the function of Polycystin-L2, potentially leading to its functional inhibition by altering intracellular calcium levels. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
This ionophore disrupts ion gradients including calcium, which is critical for Polycystin-L2 activity. The disruption of calcium homeostasis could lead to a reduction in Polycystin-L2 function. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $150.00 $350.00 | 4 | |
Used as a calcium channel blocker, this compound can interfere with the calcium permeability that Polycystin-L2 regulates, potentially inhibiting its activity by altering calcium flux. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
This compound acts as an inositol triphosphate receptor antagonist, affecting calcium signaling. Given the calcium-dependent nature of Polycystin-L2, its function may be inhibited by the disruption of calcium release from the ER. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits calcineurin. Since calcineurin is involved in dephosphorylation processes that can affect Polycystin-L2, its inhibition may lead to reduced activity of Polycystin-L2. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker that could inhibit calcium influx affecting Polycystin-L2's role in calcium signaling, potentially leading to its functional inhibition. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
By specifically antagonizing ryanodine receptors, this compound disrupts calcium release from sarcoplasmic/endoplasmic reticulum, which is crucial for the signaling pathways involving Polycystin-L2, thus potentially inhibiting its function. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $54.00 $235.00 $326.00 $551.00 $969.00 | ||
This chemical affects electrolyte flux and can alter calcium levels systemically. Disruption of calcium balance may indirectly lead to decreased activity of Polycystin-L2. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
A calcium channel blocker that would inhibit calcium influx, which is essential for the function of Polycystin-L2. The decrease in intracellular calcium could result in inhibition of Polycystin-L2's activity. | ||||||